|
|
||||||||
1 Department of Biology
and2 Pathology, McMaster University, Hamilton, Ontario, Canada L8S 4K1
and3 Department of Veterinary Microbiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1
An infectious recombinant human adenovirus type 5 (Ad5) vector, AdG12, which carries the glycoprotein gene of vesicular stomatitis virus (VSV) and expresses that gene in cultured HeLa cells was used to examine the host range of insert expression by human Ad vectors. The VSV glycoprotein was expressed in bovine, canine and murine cells when infected with AdG12 in culture. These cell lines are respectively permissive, non-permissive and semi-permissive for human Ad5 replication. Administration of the AdG12 vector to calves, piglets or dogs by either the subcutaneous or oral route resulted in the production of high titres of neutralizing antibodies to VSV. Mice injected intraperitoneally with the vector produced neutralizing antibodies and were protected against subsequent intravenous challenge with normally lethal doses of VSV. This work demonstrates the utility of human adenoviral vectors for antigen expression in a number of non-human cell lines and for the induction of an immune response to the delivered antigen in a number of species.
Keywords: adenovirus, vectors, VSV
Received 26 July 1988;
accepted 18 October 1988.
This article has been cited by other articles:
![]() |
H. M. Vordermeier, B. Villarreal-Ramos, P. J. Cockle, M. McAulay, S. G. Rhodes, T. Thacker, S. C. Gilbert, H. McShane, A. V. S. Hill, Z. Xing, et al. Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis Infect. Immun., August 1, 2009; 77(8): 3364 - 3373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gherardi and M. Esteban Recombinant poxviruses as mucosal vaccine vectors J. Gen. Virol., November 1, 2005; 86(11): 2925 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grubman and B. Baxt Foot-and-Mouth Disease Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Friedman and M. S. Horwitz Inhibition of Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activation by the Adenovirus E3-10.4/14.5K Complex J. Virol., May 3, 2002; 76(11): 5515 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Reddy, N. Idamakanti, L. A. Babiuk, M. Mehtali, and S. K. Tikoo Porcine adenovirus-3 as a helper-dependent expression vector J. Gen. Virol., November 1, 1999; 80(11): 2909 - 2916. [Abstract] [Full Text] |
||||
![]() |
A. Zakhartchouk, C Pyne, G. Mutwiri, Z Papp, M. Baca-Estrada, P Griebel, L. Babiuk, and S. Tikoo Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1 J. Gen. Virol., May 1, 1999; 80(5): 1263 - 1269. [Abstract] |
||||
![]() |
A Sanz-Parra, B Vazquez, F Sobrino, S. Cox, V Ley, and J. Salt Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins J. Gen. Virol., March 1, 1999; 80(3): 671 - 679. [Abstract] |
||||
![]() |
Y. Ilan, G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression PNAS, March 18, 1997; 94(6): 2587 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, Y. Ilan, N. R. Chowdhury, J. Guida, M. Horwitz, and J. R. Chowdhury Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period J. Biol. Chem., October 25, 1996; 271(43): 26536 - 26542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |